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A member of the unnexin family (the heterotctrameric annexin I12pl I2 camptcx purilied from porcine intestinal epithclium) was tcstcd for its ability 
to affect different calcium-dependent i rinsic lipolytic activities of rat liver hcpatic lipasc (HL). Whereas anncxin II in dc prcscnce of calcium 
failed to interfere with HL triacyl glycerol ipase (EC 3. I. I .3) activity, it inhibited HL phospholipasc A, (EC 3. I .1.32) and lysophospholipasc (EC 
3.1.1.5) activities. Inhibition could be overcome by increasing the substrate concentration. Under phospholipasc A, assay conditions, anncxin II 
did not bind to the purilicd I-IL enzyme. These results thcrcforc suggest hat only inhibitor/substrate interactions lead to inhibition of HL 
phospholipase A, and lysophospholipasc a tivities, an obviously general mechanism ofphospholipasc inhibition by annexins. Possible implications 
of HL inhibition in vivo by annexins are discussed. 
Hepatic lipasc: Annexin; Phospholipase A,; Lysophospholipase; Triacyl glycerol ipasc 
1. INTRODUCTION 2. MATERIALS AND METHODS 
Annexins represent a family of calcium- and phcs- 
pholipid-binding proteins [1,2]. Among them the gluco- 
corticoid-inducible ipocortins have been considered re- 
gulators of phospholipase A, [3,4], C [S] and D [63 ac- 
tivities. It has been suggested that phospholipases are 
non-specifically inhibited by annexins through ‘sub- 
strate depletion’ [7,8]. This process involves preferen- 
tially acidic phospholipids [7], and requires calcium in 
the micromolar ange [9]. I-IL is a lipolytic enzyme with 
broad substrate specificity and requires calcium for op- 
timal activity with triacyl glycerol as well as phospho- 
lipid substrates [lo-151. In the present study, we have 
addressed the question as to whether annexins affect 
phospholipase A, and other intrinsic lipolytic activities 
of hepatic lipase (ML) as well. 
,4bbreviutiow: HL, hepatic lipasc; [‘4C]PC, l,2-di[l-1’C]pahnitoyl-srr- 
glycero-3-phosphorylcholinc; [‘QLPC, I-[ I -‘%Z]palmitoyl-srr- 
glycero-3-phosphorylcholinc; [14C]PS, 1,2-dioleoyl-srr-glycro-3-phos- 
phoryl-L-[3=14C]serinc; [“‘C]LPS, I-oleoyl-sn-glyccro-3.phosphoryl-t- 
[3-‘%]serine; [‘HITO, glycerol tri[9,lO(n)-‘Hlolcatc. 
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2. I1 Clremicub und biu!ogicu! muterlul 
All reagents and solvents used were of analytical grrdc and. with 
the exception of those named below, were obtained from Sigma (Dci- 
senhofcn). Organic solvents and precoalcd silica gel 60 TLC plates (20 
x 5 x 0.025 cm’) were from E. Merck (Dnrmstadt). I ,2-Dipalmitoyl-srr- 
glycero-3-phospltoryl[~-methyl-1%Z]choline (52 mCi/mmol). I-[l- 
“C]palmitoyl-srz-glycero-3-phosphorylchoiinc (56 mCL’mmol), 1.2. 
dioleoyl-sn-glycero-3-phosplraryl-t_-[3-’~C]serinc (53 mCilmmol) and 
glycerol tri[9,lO(@H]olcatc (500 mCi/mmol) were purchased from 
Amersham Buchler (Braunschweig). I-Oleoyl-srr-glyccro-3-phos- 
nhoryl-L-13-“Clserinc (53 mCi/mmol) was orcnared from I .I-dioleovl- . - . a _ . . 
sn-glyccro-3-phosphoryl-L-[3-‘3C]scrine. by treatment with Crorulur 
udumuntws phospholipase AZ (EC 3.1.1.4) at 10 mM CaCll and pH 
7.2 (50 mM Tris-MCI) and purifying the resulting lysophospbatidyl- 
scrinc by thin-layer chromatography (system as described below). 
Protein A Sepharosc 4B was from Pharmacia LKB (Frciburg). The 
radioactive phospholipids were adjusted to the specific radioactivity 
rquired (so that 20,000 dpm wcrc prcscnt per assay sample), by 
adding the corresponding unlabeled phospholipid and subsqucntly 
analysing radioactivity and phosphorus. The heterotctnlmeric an- 
ncxin Il;pl I2 complex was purified from porcine intestinal cpithelium 
ns descrtbed previously [IG]. Hepatic lipasc was purified from ral liver 
homogenate by a modification [17] of the method escribed by Twtt 
et al. [I 81. Thcclcctrophorctically homogeneous preparation displayed 
a specific atalytic activity of 383 bmol fatty acid rcleascd per min at 
37°C when assayed with 2.5 mM triolcoyl glycerol suspensions in 
arabic gum in the prcsencc of Cat& BSA and Triton N-101 [lq. 
Anti-HL polyclonal antiserum against rat liver HL was r&ccl in 
rabbits as dcscribcd recently [ 17). The antiserum obtained was capable 
of inhibiting approximately I36 mU HlJkl serum. when the activity 
was assayed with the triolcoyl glycerol substrate. 
2.2. Xrospho/@ise i: , xii f;;-~~n,o.kcs~h!$m~ CLFscys 
Phospholipasc A, and lysophospholipasc a tivilics were assayed in 
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a rcnction mixture containing, in a total volume of 100 ~1. 25 mM 
ylycine/NaOH, pH 9.5, 5 mM CaCIz. diffcrcnt concentrations (up- 
proximalcly I or 100/&l) of aonicdtcd radioactively labeled substrale 
(phosphatidylserinc_ phosphatidylcholinc, lysophosphatidylserinc or 
IysophosphaGdylcholinc). and 0.5-10 ng purilicd NL. Incubation was 
carried out at 37OC for various periods of time (5-30 min). Termina- 
tion of the reaction depcndcd on the substrate used. As for the 
[‘“CJLPC substrate, the radioactive fatty acids released wcrc ontractcd 
according to the method of van den Bosch and Aarsman 1191, and 
qu;rnGtatively dctcrmined by means of a scintillation spcctromctcr. 
With [‘“C]PC. [“C]PS or [lJC]LPS as substrates, the incubation was 
tcrminuted by adding IO yl of 100 mM Na,EDTA, IO ~1 of 200 mM 
HCI and lyophilisotion. The rcsiduc was taken up in l30@ 80% (v/v) 
ethanol and lOpI of I M HCI and left at room tcmpcraturc for I h. 
After centrifugation. the residue was wushed 2 times each with 50 ~1 
50% (v/v) ethanol. Tbc resulting supernatants were subjected Lo thin- 
layer chromatography for separating radioactive substrates (phoapha- 
tidylscrine. phospbatidylcholinc or lysophosphatidylscrine) and their 
mc\abolites. This was performed cn precoatcd silica gel TLC plates, 
with a solvent mixture of chloroform/mcthanol/tricthylamine/watcr 
(30:35:34:5. by vol.). Ar values ofO.48,0.25 and 0 were obtained for 
phosphntidylscrine, IysophosphaGdylscrine and glyccrophosphoryl- 
scrine. and of0.42, 0.23 and 0 for phosphatidylcholine. lysophospba- 
tidylcholine and glyccrophosphorylcholinc. respectively. Catalytic UC- 
tivities with the [‘“C]PC, [“C]PS and [“C]LPS substrates were culcu- 
lstcd from percent mdionclivity recovered in the substrate and dea- 
cylated mctabolitc fractions. after correction for non-enzymatic sub- 
strate hydrolysis. All assays gave rates of reaction that were consumt 
throughout the specified periods of incubalion. Enzyme activities were 
proportional to the protein ConcentraGons used within the specified 
ranges. and were indcpcndent of small changes in the substrate con- 
ccntration. The enzyme xhities calculnkd from the initial reaction 
rates are expressed in U/rng (,umol of substrate hydrolyscd per min per 
mg protein at 37°C). 
Triacyl glycerol lipase activity was mcusurcd according to Jensen 
et al. [I41 as modified by Kresse et al. [17]. Brictly. the standard 
reaction mixture contained, in a total volume of 100 ,ul: 200 mM 
Tris-HCI (pH 9.0), 0.5% (w/v) arabic gum, 0.004% (w/v)Triton N-IO I. 
I% (w/v) BSA. IO mM CaCI,, 0.3 ng purified enzyme and [“HIT0 
(approximately I PM). After incubation at 37°C for 5 min, the rcac- 
tion was tcrminatcd and the catalytic activity determined as described 
recently [If]. 
In order to determine tlzc potential binding ol*annexin 11 to HL. an 
immunosorbeni gel was prepared first, The IgG fraction was isolaled 
liom drcomplemcnled (i0 mM Na,EDTA) rabbit anti-HL polyclonal 
antiserum against rat liver HL [I73 by chromatography on protein A 
Sepharosc. 270 mp of this material was coupled to 25 ml CNBr- 
activated Scpharosc 4B, as recommended by the manufacturer. SOOpug 
purified rat liver HL were exposed to an aliquot of I .5 ml immuno- 
sorbcnt gel equilibrated with buffer A (buffer medium for measuring 
phospholipase A, activity. i.e. 5 mM CaCI, in 25 mM glycinelNaOH, 
pH 9.5) in a total volume of 3 ml, at 0°C for 3 h. The gel was washed 
3 limes each with 5 ml ice-cold buffer A. Under lhcsc conditions the 
immunosorbcnt was capable of binding approximately IOpg purified 
HL/m! gel. A I ml aliquot of the immunosorbcm gel to which IO,ug 
HL had been bound was filled into a column. 50~6 anncxin lIzpI II 
in 25~1 were applied to this column, and the column was subsequently 
washed with IO ml buffer A. The elusnts were analysed for protein 
content and for their capacity to inhibit HL activity with phosphati- 
dylserine as a substrate. 
2.5. Chmical arrulysis 
Inorganic phosphorus was determined after washing [20] as de- 
scribed by Chcn et al. [‘I]. Protein content was detcrmincd according 
to Lafllcr and Kunze [22] using bovine serum albumin as standard. 
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Fig. I. Effecls of annexin lIzpI I: on lipolytic activities of purified HL 
with different substrates. Phospholipasc A, and lysopbospholipasc 
acGvitics were determined as described under section 2. Hydrolysis of 
I .3yM [‘“C]LPC (v) was assayed with 5 ng HLand 20 min incubation 
lime (dnncxin-free controls: 0.19-t0.01 U/m& of I.4 ,&I [‘“C]LPS (A) 
with 5 ng HL and 20 min incubation time (annexin-free controls: 
0.3G+O.O4 U/m& and of I22 PM [“C]LPS (A) with 20 ng HL and 30 
min incubation time (annexin-free conlrols: I .i38?0. I2 U/mg). Hy- 
drol+ ;;fO.9 PM [lJC]PC (3) wds determined using 2.5 ng HL and 
30 min r’ .,$~ubation time (annexin-free controls: 0.33t0.02 U/m&, and 
of98Lth: [lJC]PC (0) with 20 ng HL and 30 min (controls: 1.75+0.02 
U/mg). Hydrolysis of I .2 PM [VIPS (0) was assayed with 0.5 ng HL 
and f0 min incubation timc(annexin-free controls 3.0+0.9 U/m& and 
of I02 ,uM [“C]PS (H) with 5 ng HL and IO min (control 9.2?2,8 
U/mg). Each data point represents the mean of triplicate detcrmina- 
tions. SD. did not exceed 9%. 
3. RESULTS AND DISCUSSION 
HL offers the unique opportunity to study potential 
effects of annexins on different lipolytic activities of one 
and the same enzyme including its catalytic action on 
phospholipid hydrolysis. Since inhibition by anncxins 
of phospholipases has generally been observed only at 
substrate concentrations below IO-’ M [3-G], we have 
used those conditions also in the present study. 
Triacyl glycerol lipase activity of purified HL was 
independent of the presence of annexin II. When as- 
sayed with 0.3 ng HL and 5 min incubation time, hy- 
drolysis of [‘HIT0 (1.1 PM) was 0.41-CO.02 U/mg, and 
in the presence of 5 jig annexin II 0.421-0.03 U/mg. This 
indicates that even in the presence of calcium the triacyl 
glycerol-hydrolysing activity of HL is not affected by 
this annexin. 
In detergent-free medium, rates of phospholipid hy- 
drolysis catalysed by purified HL were optimal at 5 mM 
CaCl? and pH 9.5, irrespective of the phospholipid spe- 
cies studied. Absolute values depended on the phos- 
pholipid type used. However, it has to be kept in mind 
that analyses of substrate specificity and kinetics are 
problematic due to the dif’ficulty in controlling the inter- 
facial quality of pure substrates [23], i.e. different phos- 
pholipids assume different physical structures depend- 
ing on their molecular geometry and on the composition 
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of the aqueous environment [24,25]. Under our assay 
conditions, HL-catalyscd hydrolysis of [“‘C]PS signifi- 
cantly exceeded that of [“C’JPC (Fig, 1). The observed 
preference for phosphatidylserine over phosphatidyl- 
choline was inversed, when these phospholipids were 
presented together with Triton X-100 in the form of 
mixed micelles (data not shown). The catalytic rates 
which had been measured in the absence of detergents 
differ slightly from those obtained in other laboratories 
[ 15,2G]. This is most certainly due to different assay 
conditions, in particular pH, detergent and calcium con- 
centrations. 
In the absence of detergents, HL displayed intrinsic 
lysophospholipase activity. Pure [“C]LPC and [“C]LPS 
in micromolar concentrations were hydrolyscd at rates 
slightly below those of [“‘C]PC and [“C]PS, respectively 
(Fig. I), HL also catalyses deacylation of the 2-acyl- 
lysophospholipids which initially formed by its action 
on diacylphospholipids. Under standard assay condi- 
tions, about 69-78% of the metabolites formed from 
diacylphospholipids were identified as lysophospholi- 
pids. 
HL activity with diacyl- as well as monoacylphospho- 
lipid (lysophospholipid) substrates was inhibited by an- 
nexin II in vitro (Fig. 1). The degree of this inhibition 
depended on the concentration of the phospholipid and 
on the nature of the phospholipid’s polar head group. 
Thtts, inhibition was low with the zwitterionic phospha- 
tidylcholine and not detectable with the Iysophosphati- 
dylcholine substrate, but it became clearly evident with 
the acidic phosphatidylserine and lysophosphatidyl- 
serine (Fig. 1). Annexin II-induced inhibition of ML 
activity with each phospholipid substrate was increas- 
ingly reduced by raising the substrate concentration 
(Fig. 1). 
It has been suggested that annexins generally interact 
only with the phospholipid substrate and not with the 
enzyme. This mode of inhibition, i.e. a substrate deple- 
tion by annexins, has been demonstrated for phospho- 
lipase AZ [7,8] and phosphatidylinositol-specific phos- 
pholipase C [S]. In our experiments, the lack of inhibi- 
tiotl of trioleoyl glycerol hydrolysis by annexin II in the 
presence of calcium already led us to assume that there 
is no HL/annexin II interaction. Direct evidence was 
obtained by experiments on HL immunoadsorbed to 
Sepharose. No binding of annexin II to this enzyme was 
detectable, since annexin II was completely recovered 
when the column flow-through was analysed for protein 
and inhibition of phospholipase Al activity (data not 
shown). Hence we conclude that the mechanism of in- 
hibition of HL phospholipase Al and lysophospholi- 
pase activities by the annexin II?pl lz complex is iden- 
tical to that of other phospholipases, i.e. inhibition by 
inhibitor/ substrate interactions. 
Rat liver ML in its mature form is a 59 kDa glyco- 
protein synthesised inhepatocytes and secreted into the 
blood stream [27,28]. Here it binds to the endothelial 
plasma membranes of liver, adrenals and ovaries [28- 
30], where it obviously plays an important role in lipo- 
protein metabolism [31,32]. Glucocorticoid-induced 
alterations of some plasma lipoproteins [33] have been 
reported to be due to decreased ML activity [34,35]. 
Since it has been found that glucocorticoids inhibit HL 
biosynthesis and/or secretion [34,35], lipoprotein 
changes mediated by glucocorticoids [33] have been ex- 
plained by this mechanism. Our in vitro studies now 
suggest hat interference of glucocorticoid-induced an- 
nexins with HL activity may contribute to the genera- 
tion of disturbed lipoprotein patterns. Lack of inhibi- 
tion by annexin II of ML-catalysed triolein hydrolysis 
seems to be in contrast o the findings that glucocor- 
ticoids reduce lipoprotein triglyceride catabolism [33- 
351. However, since phospholipids (and apolipopro- 
teins) surround lipoprotein particles, phospholipid hy- 
drolysis must precede triglyceride hydrolysis (otherwise 
the latter substrate does not become accessible to HL). 
In other words, hydrolysis of triglycerides i impaired, 
as soon as phospholipid hydrolysis is inhibited, 
Whether or not annexin-mediated HL inhibition also 
occurs in vivo remains yet to be clarified. Although 
some experimental evidence suggests that annexins are 
released into the blood stream [36,37], it is not yet clear 
whether (prolonged) treatment with glucocorticoids in 
vivo increases biosynthesis and secretion of annexins 
into the vascular lumen. 
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